Anna Estival
30 Papers
29 Citations
Anna Estival is an academic researcher. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 5, co-authored 22 publications.
Chat about Author
Papers
Pseudoprogression as an adverse event of glioblastoma therapy
Carmen Balana,Jaume Capellades,Estela Pineda,Anna Estival,Josep Puig,Sira Domenech,Eugenia Verger,Teresa Pujol,Maria Martinez-Garcia,Laura Oleaga,JoseMaria Velarde,Carlos Mesia,Rafael Fuentes,J. Marruecos,Sonia Del Barco,Salvador Villà,Cristina Carrato,Oscar Gallego,Miguel Gil-Gil,Jordi Craven-Bartle,Francesc Alameda +20 more
TL;DR: PsP confounds the evaluation of disease and does not confer a survival advantage in glioblastoma, and only MGMT methylation status was associated to PsP.
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
Ernest Nadal,Delvys Rodriguez-Abreu,Marta Simó,Bartomeu Massuti,Oscar Juan,G. Huidobro,Rafael López,Javier de Castro,Anna Estival,Joaquín Mosquera,Ivana Sullivan,Enriqueta Felip,Ana Blasco,M. Guirado,E. Pereira,Noelia Vilariño,Valentin Navarro,Jordi Bruna +17 more
TL;DR: Atezolizumab plus carboplatin and pemetrexed demonstrates activity in patients with advanced nonsquamous NSCLC with untreated brain metastases with an acceptable safety profile.
50
Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns.
S. Comas,E. Luguera,J. Molero,Carmen Balana,Anna Estival,S. Castañer,Cristina Carrato,Cristina Hostalot,Pilar Teixidor,S. Villà +9 more
TL;DR: The results suggest that glioblastoma contact with the SVZ appears to be an independent prognostic factor for poor PFS, and the presence of an SVZ-contacting tumor was associated with more aggressive recurrences and a higher rate of contralateral relapses.
21
Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation.
Miriam Magallón-Lorenz,Juana Fernández-Rodríguez,Ernest Terribas,Edgar Creus-Batchiller,Cleofé Romagosa,Anna Estival,Diana Pérez Sidelnikova,Héctor Salvador,Alberto Villanueva,Ignacio Blanco,Meritxell Carrió,Conxi Lázaro,Eduard Serra,Bernat Gel +13 more
TL;DR: In this paper, a comprehensive genomic analysis of MPNST cell lines and tumors was performed to explore the status of CDKN2A and reveal a previously unnoticed high frequency of chromosomal translocations involving CDN2A.
15
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.
Alberto Ruano-Ravina,Mariano Provencio,Virginia Calvo de Juan,Enric Carcereny,Anna Estival,Delvys Rodriguez-Abreu,Gretel Benítez,R. López-Castro,Marta Belver,María Guirado-Risueño,Carlos Guirao-Rubio,Ana Blasco,Bartomeu Massuti,Ana Laura Ortega,Manuel Cobo,Joaquín Mosquera-Martínez,Carlos Aguado De La Rosa,Joaquim Bosch-Barrera,Amparo Sanchez-Gastaldo,Edel del Barco Morillo,Oscar Juan,Manuel Domine,Jose Manuel Trigo,Diego Pereiro Corbacho,Juana Oramas +24 more
TL;DR: There seems to be no differences in lung cancer characteristics by sex at the time at diagnosis on stage, specific symptoms or number of symptoms.